Tianshui Zhongxing Bio-technology 众兴菌业
4 significant filings since 30 May 2026: 1 on share pledge, 1 on guarantee or financial assistance and 1 on equity incentive, and 1 other kind. The latest, on 5 Sep 2026: 关于调剂担保额度及对外担保进展公告. On 15 Jul 2026 the company said it expects net profit for the period ending 30 Jun 2026 to rise by 160.79% to 189.77% from the same period a year earlier.
自 30 May 2026 起有 4 份重大公告：share pledge 1 份、guarantee or financial assistance 1 份、equity incentive 1 份，另有 1 类。最新一份（5 Sep 2026）：关于调剂担保额度及对外担保进展公告。15 Jul 2026 公司预告截至 30 Jun 2026 的净利润较上年同期上升 160.79% 至 189.77%。
| FY2026 | FY2027 | |
|---|---|---|
| Now 当前 | 1.03 | 1.11 |
| 7 days ago | 1.03 | 1.11 |
| 30 days ago | 1.03 | 1.11 |
| 60 days ago | 1.03 | 1.13 |
| 90 days ago | 2 brokers | 2 brokers |
Consensus is the median of each broker's latest forecast from the 120 days before each date. With fewer than 3 brokers, the broker count is shown. 一致预期为各券商在该日期前 120 天内最新预测的中位数；不足 3 家时显示券商数。
Consensus was 1.03 in both Jul 2026 and Sep 2026. The shaded band runs from the lowest to the highest broker forecast.
| FY2026 | FY2027 | |
|---|---|---|
| Last 30 days | ▲ 0 ▼ 0 = 0 | ▲ 0 ▼ 0 = 0 |
| Last 90 days | ▲ 0 ▼ 0 = 1 | ▲ 0 ▼ 0 = 1 |
Each broker's latest forecast is compared with its previous forecast for the same year. A move within 0.5% counts as unchanged. 每家券商的最新预测与其对同一年度的上一次预测比较，变动在 0.5% 以内视为不变。
A surprise needs at least 3 brokers forecasting in the 120 days before the filing. FY2025 had 1 and FY2024 had 0.